PrEP Among MSM and TG in Myanmar
PrEP Among MSM and TG in Myanmar
HIV is concentrated among key populations in Myanmar. Globally, HIV-prevalence among
 transgender (TG) women is one of the highest; laboratory-confirmed prevalence is reported up
 to 40%. In September 2015, WHO recommended the use of Pre-Exposure Prophylaxis (PrEP) for
 people at substantial risk of HIV as part of a combination HIV prevention strategy. A
 demonstration project will take place to implement and evaluate the uptake and effectiveness
 of PrEP among MSM, and TG women in a clinic in Hlaingtharyar township, Yangon. The aim is to
 describe PrEP uptake, as well as HIV-seroconversion and STI infection rates among those who
 use PrEP.
Inclusion Criteria:

 -  HIV-negative

 -  No suspicion of acute HIV infection

 -  Substantial risk of HIV infection

 -  Creatinine clearance is more than 30 ml/min

 -  Willingness to use PrEP as prescribed, including periodic HIV testing

 -  Willingness to sign informed consent

 Exclusion Criteria:

 • Anyone who is not eligible with the inclusion criteria